Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP476880.RA5eRtN7p6SLnOsW7YnQbtuE6L5tC_E-OpxeEZttJ-zJg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP476880.RA5eRtN7p6SLnOsW7YnQbtuE6L5tC_E-OpxeEZttJ-zJg130_assertion type Assertion NP476880.RA5eRtN7p6SLnOsW7YnQbtuE6L5tC_E-OpxeEZttJ-zJg130_head.
- NP476880.RA5eRtN7p6SLnOsW7YnQbtuE6L5tC_E-OpxeEZttJ-zJg130_assertion wasGeneratedBy ECO_0000203 NP476880.RA5eRtN7p6SLnOsW7YnQbtuE6L5tC_E-OpxeEZttJ-zJg130_provenance.
- NP476880.RA5eRtN7p6SLnOsW7YnQbtuE6L5tC_E-OpxeEZttJ-zJg130_assertion wasDerivedFrom befree-20150227 NP476880.RA5eRtN7p6SLnOsW7YnQbtuE6L5tC_E-OpxeEZttJ-zJg130_provenance.
- NP476880.RA5eRtN7p6SLnOsW7YnQbtuE6L5tC_E-OpxeEZttJ-zJg130_assertion SIO_000772 21389325 NP476880.RA5eRtN7p6SLnOsW7YnQbtuE6L5tC_E-OpxeEZttJ-zJg130_provenance.
- NP476880.RA5eRtN7p6SLnOsW7YnQbtuE6L5tC_E-OpxeEZttJ-zJg130_assertion evidence source_evidence_literature NP476880.RA5eRtN7p6SLnOsW7YnQbtuE6L5tC_E-OpxeEZttJ-zJg130_provenance.
- NP476880.RA5eRtN7p6SLnOsW7YnQbtuE6L5tC_E-OpxeEZttJ-zJg130_assertion description "[Although IFNα at present remains an experimental form of therapy for patients with myeloid malignancies, these promising results suggest that it may become again an important component of the therapeutic arsenal for this group of hematologic malignancies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP476880.RA5eRtN7p6SLnOsW7YnQbtuE6L5tC_E-OpxeEZttJ-zJg130_provenance.